- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Proteolysis targeting chimeras (PROTACs) in cancer therapy ; volume:39 ; number:1 ; day:15 ; month:9 ; year:2020 ; pages:1-9 ; date:12.2020
Journal of experimental & clinical cancer research ; 39, Heft 1 (15.9.2020), 1-9, 12.2020
- Urheber
-
Ocaña, Alberto
Pandiella, Atanasio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-020-01672-1
- URN
-
urn:nbn:de:101:1-2020110319595840552076
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ocaña, Alberto
- Pandiella, Atanasio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras“ (PROTACs): Synthese und biologische Testung
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
Biological Assessment and Tests of Activity of Two Novel Proteolysis Targeting Chimeras (PROTACs)
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity
Interleukin-6-interleukin-11 receptor chimeras reveal ionomycin-induced proteolysis beyond ADAM10
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras“ (PROTACs): Synthese und biologische Testung
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
Biological Assessment and Tests of Activity of Two Novel Proteolysis Targeting Chimeras (PROTACs)
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity
Interleukin-6-interleukin-11 receptor chimeras reveal ionomycin-induced proteolysis beyond ADAM10
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras“ (PROTACs): Synthese und biologische Testung
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
Biological Assessment and Tests of Activity of Two Novel Proteolysis Targeting Chimeras (PROTACs)
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity